- 5 Frequently Asked Questions about Drug Diversion Management (drugtopics.com)
In reality, nearly half (44%) of hospital pharmacists experienced a diversion event within the past 12 months, which is up from 37% in 2019. The COVID-19 pandemic has exacerbated this “hidden epidemic,” a multi-faceted challenge which poses serious risks to patients, clinicians and healthcare systems...Here are 5 questions frequently asked by health systems seeking to accelerate and improve their efforts to detect and mitigate drug diversion incidents...READ MORE
- What are the biggest challenges in identifying drug diversion?
- How have responsibilities for addressing and resolving drug diversion issues evolved?
- What offers the biggest opportunity to improve diversion identification?
- When selecting automated systems and software, which capabilities are most critical?
- How do you justify the cost of technology in a difficult economic environment?
- Lawmakers aim to move ‘very quickly’ to pass bill mandating electronic prior authorization for MA plans (fiercehealthcare.com)
Lawmakers behind the Improving Seniors’ Timely Access to Care Act...not only requires electronic prior authorization for MA plans, but also requires the Department of Health and Human Services to create a process for faster decisions on items and services that commonly get approved...While the bill only applies to MA plans, lawmakers hope to eventually tackle more types of insurance such as commercial plans...READ MORE
- Lawmakers seek greater oversight of billions in opioid settlement funds projected for the state (thenevadaindependent.com)
A few state lawmakers are hoping to establish greater legislative oversight over how the state spends billions of dollars in opioid settlement funds projected to be won by the attorney general in litigation throughout the next decade...SB390, a bill presented by Sen. Julia Ratti (D-Sparks) and sponsored by the Senate Health and Human Services Committee, would create a state fund to house proceeds from opioid settlements, such as the $45 million Nevada is set to receive from the settlement of a lawsuit against consulting firm McKinsey & Company, which provided services for opioid manufacturers...READ MORE
- Vaccination with Sputnik V launched in India (worldpharmanews.com)
The Russian Direct Investment Fund announces the launch of vaccination with the Russian Sputnik V vaccine against coronavirus in India...Sputnik V has become the first foreign-made vaccine that is used in India contributing to the world’s largest COVID-19 vaccination campaign. Inoculations with Sputnik V in Hyderabad...followed the arrival of the first batch of the vaccine in India on May 1, 2021...Sputnik V was approved for use in India on April 12, 2021 and granted an emergency use authorization...READ MORE
- Needles in haystacks: a new generation of AI-enhanced drug discovery companies (pharmaceutical-technology.com)
The search for novel therapies has long been a trial-and-error process that costs drug companies a vast amount of time and money. Now, with artificial intelligence (AI) set to transform the pharmaceutical industry more than any other emerging technology, a growing number of pharma and biotech groups are harnessing the cutting-edge tech to minimise the hit-and-miss nature of R&D and discover new therapies with previously impossible speed and accuracy...READ MORE
- Six Trends to Watch in the New Healthcare Economy (drugchannels.net)
The pace of innovation, the rise of consumerism, an aging population, and the movement toward price transparency means healthcare companies must become more agile and insightful than ever. Six trends have emerged as the top issues affecting healthcare businesses today...READ MORE
- LEVERAGING BIG DATA
- SEEING DISRUPTION AS THE NORM
- EXPANDING THE ROLE OF PHARMACISTS
- FOCUSING ON TELEHEALTH AND DIGITAL CARE MODELS
- AGING POPULATION PRESSURING RETAIL PHARMACY
- ENGAGING PATIENTS TO IMPROVE ADHERENCE
- Manufacturers’ 340B Restrictions On Contract Pharmacies Draw Ire (pharmacypracticenews.com)STATEMENT ON HRSA ORDERING DRUG COMPANIES TO RESTORE 340B DISCOUNTS ON DRUGS DISPENSED AT COMMUNITY PHARMACIES (340bhealth.org)
Beginning last summer, several drug manufacturers announced they would no longer extend 340B drug pricing to contract pharmacies. The manufacturers said the restrictions are part of a much-needed adjustment to a program that has seen “egregious markups” and other abuses. But the pharmacies caught up in the crossfire say the policy is having unintended consequences, including compromised patient care...Affected 340B facilities say they also are worried about the financial fallout if the restrictions continue...READ MORE
- Eli Lilly wants court to halt HRSA from issuing penalties over 340B contract pharmacy moves (fiercehealthcare.com)
Eli Lilly is asking a federal court to stop the federal government from imposing any penalties over its decision to restrict sales of 340B-discounted products to contract pharmacies...The request for a preliminary injunction and temporary restraining order...comes less than a week after the Health Resources and Services Administration wrote to Lilly and five other drug companies over the contract pharmacy restrictions...The injunction and order show that drug companies appear likely to fight HRSA’s order to immediately offer 340B-discounted drugs to contract pharmacies, which are third-party entities that dispense drugs on behalf of the 340B covered entities...READ MORE
- Nevada’s drug transparency program could get two years of funding as lawmakers consider expanding its scope (thenevadaindependent.com)
Four years after passing the state’s first drug transparency law, lawmakers may finally put dollars behind the effort as they continue to build upon the original legislation this session...Members of the Senate Finance Committee this week considered a $780,000 fiscal note from the Department of Health and Human Services on the latest drug transparency bill, SB380, which would allow state health officials to transfer the existing drug transparency database to the state’s Enterprise Information Technology Services Division, where it would live and be maintained moving forward. It also would allow the state to hire a pharmacist to manage the drug transparency program and a management analyst to assist with the program’s facilitation...READ MORE
- Technology Advances Are Needed to Advance the Profession (drugtopics.com)
One day, my wife Denise and I went to our local bank with a plastic card and put it in the machine. We had the option of withdrawing either $25 or $50 out of our checking account. The money dropped down in an envelope with the cash inside. This was amazing technology for 1981. I then went to work and pulled out the Smith Corona typewriter and started typing prescription labels...Yesterday, I went to our warehouse club and pulled up to the gas pumps. I took out my phone and waved it at the QR code on the screen. I began pumping my gas without ever getting my wallet out of my pocket. I checked my email and saw I had spent $28.54 on pump #4 at 7:46 am...When I stand in front of my pharmacy computer for 10 hours at a time, I often wonder why this technology seems so far behind the other technology I use daily. If we want to move this profession toward more patient-centric care, we must have the tools to do that. All I ask is that my pharmacy computer have the same technology as my gas pump...READ MORE